Skip to main content
TipRanks
Go Ultimate75% OFF

John Phd Longenecker Insider Profile

4 Followers

John Phd Longenecker, Director at Pacira Pharmaceuticals, holds 18.82K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 10.00K shares in Rein Therapeutics (Ticker: RNTX).

John Phd Longenecker's Trading History

PCRX
Pacira Pharmaceuticals
Mar 07, 2022DirectorUninformative Buy75.67K$685.72K
RNTX
Rein Therapeutics
Aug 14, 2018President & CEOInformative Buy24.50K$6.13K

You May Also Like

John Phd Longenecker insider profile FAQ

What is the percentage of profitable transactions made by John Phd Longenecker?
The percentage of profitable transactions made by John Phd Longenecker is 20%.
What is the average return per transaction made by John Phd Longenecker?
The average return per transaction made by John Phd Longenecker is -20.70%.
What stocks does John Phd Longenecker hold?
John Phd Longenecker holds: PCRX, RNTX stocks.
What was John Phd Longenecker’s latest transaction?
John Phd Longenecker’s latest transaction was an Uninformative Buy of $75.67K.
What was John Phd Longenecker's most profitable transaction?
John Phd Longenecker’s most profitable transaction was an Informative Sell of PCRX stock on March 7, 2022. The return on the trade was 43.20%.
What is John Phd Longenecker's role in Pacira Pharmaceuticals?
John Phd Longenecker's role in Pacira Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.